Patents by Inventor Munetomo Matsuda
Munetomo Matsuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957660Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: GrantFiled: September 22, 2022Date of Patent: April 16, 2024Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20240033248Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: September 29, 2023Publication date: February 1, 2024Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
-
Patent number: 11826352Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: GrantFiled: May 5, 2021Date of Patent: November 28, 2023Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20230030285Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: September 22, 2022Publication date: February 2, 2023Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
-
Patent number: 11478450Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: GrantFiled: December 23, 2021Date of Patent: October 25, 2022Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20220110915Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: December 23, 2021Publication date: April 14, 2022Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
-
Patent number: 11241416Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: GrantFiled: March 26, 2021Date of Patent: February 8, 2022Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20210251965Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: May 5, 2021Publication date: August 19, 2021Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
-
Publication number: 20210212990Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: March 26, 2021Publication date: July 15, 2021Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
-
Patent number: 10987341Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: GrantFiled: May 12, 2020Date of Patent: April 27, 2021Assignee: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20200268712Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.Type: ApplicationFiled: May 12, 2020Publication date: August 27, 2020Applicant: Mitsubishi Tanabe Pharma CorporationInventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
-
Publication number: 20180207131Abstract: The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.Type: ApplicationFiled: March 20, 2018Publication date: July 26, 2018Inventors: Kazuhiko Ozaki, Munetomo Matsuda, Tetsurou Nishimura, Kenjirou Takayanagi
-
Patent number: 9956203Abstract: The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.Type: GrantFiled: November 29, 2010Date of Patent: May 1, 2018Assignee: Mitsubishi Tanabe Pharma CorporationInventors: Kazuhiko Ozaki, Munetomo Matsuda, Tetsurou Nishimura, Kenjiro Takayanagi
-
Publication number: 20120271270Abstract: The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.Type: ApplicationFiled: June 29, 2012Publication date: October 25, 2012Applicants: Mitsubishi Plastics, Inc., Mitsubishi Tanabe Pharma CorporationInventors: Kazuhiko Ozaki, Munetomo Matsuda, Tetsurou Nishimura, Kenjirou Takayanagi, Hiroshi Kanedo
-
Publication number: 20110068037Abstract: The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.Type: ApplicationFiled: November 29, 2010Publication date: March 24, 2011Applicant: Mitsubishi Tanabe Pharma CorporationInventors: Kazuhiko Ozaki, Munetomo Matsuda, Tetsurou Nishimura, Kenjirou Takayanagi, Hiroshi Kaneko
-
Publication number: 20100320215Abstract: The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.Type: ApplicationFiled: November 21, 2008Publication date: December 23, 2010Applicant: MITSUBISHI TANABE PHARMA CORPORATIONInventors: Kazuhiko Ozaki, Munetomo Matsuda, Tetsurou Nishimura, Kenjirou Takayanagi, Hiroshi Kaneko